January 26, 2012

Amgen buys Micromet for anti-leukemia drug

Biotech giant Amgen said Thursday it was buying the German-American cancer research firm Micromet, giving it access to Micromet's promising leukemia therapy.

Amgen said it would pay $1.16 billion for Micromet, founded by a team of to tap the potential of T-cell therapies to fight cancer.

The company, based in Rockville, Maryland, has developed blinatumomab, a T-cell based treatment for and possibly non-Hodgkin's lymphoma that is still undergoing testing.

"Blinatumomab will serve as an important complement to our oncology pipeline and is representative of our corporate strategy, which is focused on developing and successfully commercializing therapeutics to treat patients with grievous illness," Amgen chief executive Kevin Sharer said in a statement.

The deal is worth $11 a share to Micromet shareholders. The Nasdaq-listed company's price jumped 31.9 percent to $10.92 after the announcement.

California-based Amgen's share price fell 1.4 percent to $68.25.

(c) 2012 AFP

Citation: Amgen buys Micromet for anti-leukemia drug (2012, January 26) retrieved 23 April 2024 from https://medicalxpress.com/news/2012-01-amgen-micromet-anti-leukemia-drug.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Patient privacy focus of Amgen suit
 shares

Feedback to editors
The consumption of certain food additive emulsifiers could be associated with the risk of developing type 2 diabetes

54 minutes ago
Perinatal transmission of HIV can lead to cognitive deficits

54 minutes ago
Study finds suicidal behaviors increased by over 50% in Catalonia, Spain after the COVID-19 pandemic

2 hours ago
Why do we move slower the older we get? New study delivers answers

2 hours ago
Stress activates brain regions linked to alcohol use disorder differently for women than men, finds study

3 hours ago
Chemical tool illuminates pathways used by dopamine, opioids and other neuronal signals

3 hours ago
Gentle defibrillation for the heart: A milder method developed by researchers for cardiac arrhythmias

4 hours ago
Q&A: Research shows neural connection between learning a second language and learning to code

4 hours ago
Gut microbiota acts like an auxiliary liver, study finds

4 hours ago
Higher light levels may improve cognitive performance

4 hours ago
Load comments (0)